CODX New York City , May 28, 2020 (GLOBE NEWSWIRE) -- Analysts from H.C. Wainwright , Maxim Group and Litchfield Hills have all upgraded or reiterated Co-Diagnostics (NASDAQ: CODX) as Buy rating in the past two weeks. The 3 analysts offering 12-month price forecasts for Co-Diagnostics Inc have a median target of 35.00, with a high estimate of 36.00 and a low estimate of 30.00. The median estimate represents a +99.32% increase from yesterday's closing price of $17.56 .
Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions
![](//investorshub.advfn.com/uimage/uploads/2016/5/12/gnujr177713_CA.jpg)